Welcome to LookChem.com Sign In|Join Free

CAS

  • or

620-72-4

Post Buying Request

620-72-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

620-72-4 Usage

Chemical Properties

Solid

Uses

Phenyl Bromoacetate is an intermediate used to prepare 1,2,3-triazole derivatives as cannabinoid CB1 receptor antagonists. It is also used in the synthesis of [1,2,4]triazino[4,3-a] benzimidazole acetic acid derivatives as selective aldose reductase inhibitors.

Synthesis Reference(s)

Synthetic Communications, 16, p. 1043, 1986 DOI: 10.1080/00397918608056346

General Description

Phenyl bromoacetate is an aromatic ester.

Check Digit Verification of cas no

The CAS Registry Mumber 620-72-4 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 6,2 and 0 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 620-72:
(5*6)+(4*2)+(3*0)+(2*7)+(1*2)=54
54 % 10 = 4
So 620-72-4 is a valid CAS Registry Number.
InChI:InChI=1/C8H7BrO2/c9-6-8(10)11-7-4-2-1-3-5-7/h1-5H,6H2

620-72-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H60464)  Phenyl bromoacetate, 98%   

  • 620-72-4

  • 5g

  • 269.0CNY

  • Detail
  • Alfa Aesar

  • (H60464)  Phenyl bromoacetate, 98%   

  • 620-72-4

  • 50g

  • 2193.0CNY

  • Detail

620-72-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name Phenyl Bromoacetate

1.2 Other means of identification

Product number -
Other names Acetic acid, bromo-, phenyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:620-72-4 SDS

620-72-4Synthetic route

2-Bromoacetyl bromide
598-21-0

2-Bromoacetyl bromide

phenol
108-95-2

phenol

phenyl 2-bromoacetate
620-72-4

phenyl 2-bromoacetate

Conditions
ConditionsYield
Heating;92%
With triethylamine In dichloromethane at 0℃; for 1.5h; Inert atmosphere;81%
at 80℃; for 1h;77%
methoxybenzene
100-66-3

methoxybenzene

2-Bromoacetyl bromide
598-21-0

2-Bromoacetyl bromide

phenyl 2-bromoacetate
620-72-4

phenyl 2-bromoacetate

Conditions
ConditionsYield
With zinc(II) chloride at 50 - 70℃; for 3.5h;38%
bromoacetic acid
79-08-3

bromoacetic acid

phenol
108-95-2

phenol

phenyl 2-bromoacetate
620-72-4

phenyl 2-bromoacetate

Conditions
ConditionsYield
(i) DCC, THF, (ii) /BRN= 506167/; Multistep reaction;
With dmap; dicyclohexyl-carbodiimide In dichloromethane at 20℃;
<β.β-dibromo-vinyl>-phenyl ether

<β.β-dibromo-vinyl>-phenyl ether

phenyl 2-bromoacetate
620-72-4

phenyl 2-bromoacetate

Conditions
ConditionsYield
With acetic acid at 100℃; im geschlossenen Rohr;
bromoacetimidic acid phenyl ester hydrochloride

bromoacetimidic acid phenyl ester hydrochloride

phenyl 2-bromoacetate
620-72-4

phenyl 2-bromoacetate

Conditions
ConditionsYield
With water
hydrogenchloride
7647-01-0

hydrogenchloride

diethyl ether
60-29-7

diethyl ether

bromoethynyl-phenyl ether

bromoethynyl-phenyl ether

mercury(II) diacetate
1600-27-7

mercury(II) diacetate

phenyl 2-bromoacetate
620-72-4

phenyl 2-bromoacetate

Conditions
ConditionsYield
at 10℃;
water
7732-18-5

water

2-bromo-acetimidic acid phenyl ester; hydrochloride

2-bromo-acetimidic acid phenyl ester; hydrochloride

phenyl 2-bromoacetate
620-72-4

phenyl 2-bromoacetate

4-bromo-phenol
106-41-2

4-bromo-phenol

phenyl 2-bromoacetate
620-72-4

phenyl 2-bromoacetate

Conditions
ConditionsYield
With sulfuric acid In (2S)-N-methyl-1-phenylpropan-2-amine hydrate; acetic anhydride
phenyl 2-bromoacetate
620-72-4

phenyl 2-bromoacetate

3S-3-<<(1,1-Dimethylethoxy)carbonyl>amino>-2,5-dioxo-2,3,4,5-tetrahydro-1H-1-benzazepine
74802-29-2

3S-3-<<(1,1-Dimethylethoxy)carbonyl>amino>-2,5-dioxo-2,3,4,5-tetrahydro-1H-1-benzazepine

Benzyl 2-(3S-3-<<(1,1-Dimethylethoxy)carbonyl>amino>-2,5-dioxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)-ethanoate
128776-36-3

Benzyl 2-(3S-3-<<(1,1-Dimethylethoxy)carbonyl>amino>-2,5-dioxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)-ethanoate

Conditions
ConditionsYield
With tetrabutylammomium bromide; potassium carbonate In acetone98%
phenyl 2-bromoacetate
620-72-4

phenyl 2-bromoacetate

triphenylphosphine
603-35-0

triphenylphosphine

((triphenyl)-λ5-phosphanylidene)acetic acid phenyl ester
32443-55-3

((triphenyl)-λ5-phosphanylidene)acetic acid phenyl ester

Conditions
ConditionsYield
Stage #1: phenyl 2-bromoacetate; triphenylphosphine In chloroform at 23℃; Inert atmosphere;
Stage #2: With sodium hydroxide In water
96%
Stage #1: phenyl 2-bromoacetate; triphenylphosphine In benzene at 20℃; for 18h;
Stage #2: With sodium hydroxide In dichloromethane; water for 0.5h;
Multi-step reaction with 2 steps
1: toluene / 12 h / Inert atmosphere
2: sodium hydroxide / dichloromethane; water / 0.33 h / 20 °C
View Scheme
phenyl 2-bromoacetate
620-72-4

phenyl 2-bromoacetate

(1R,9S,10R,11R,12R)-12-Amino-6-bromo-3,4-dimethoxy-5-methyl-13-(toluene-4-sulfonyl)-13-aza-tricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10,11-diol
244126-36-1

(1R,9S,10R,11R,12R)-12-Amino-6-bromo-3,4-dimethoxy-5-methyl-13-(toluene-4-sulfonyl)-13-aza-tricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-10,11-diol

C24H27BrN2O7S

C24H27BrN2O7S

Conditions
ConditionsYield
With 4 A molecular sieve; methyloxirane In acetonitrile at 80℃; Cyclization;92%
phenyl 2-bromoacetate
620-72-4

phenyl 2-bromoacetate

4-(4-cyclopropylnaphthalen-1-yl)-4Η-1,2,4-triazole-3-thiol
1533519-84-4

4-(4-cyclopropylnaphthalen-1-yl)-4Η-1,2,4-triazole-3-thiol

phenyl 2‐((4‐(4‐cyclopropylnaphthalen‐1‐yl)‐4H‐1,2,4‐triazol‐3‐yl)thio)acetate

phenyl 2‐((4‐(4‐cyclopropylnaphthalen‐1‐yl)‐4H‐1,2,4‐triazol‐3‐yl)thio)acetate

Conditions
ConditionsYield
Stage #1: 4-(4-cyclopropylnaphthalen-1-yl)-4Η-1,2,4-triazole-3-thiol With triethylamine In isopropyl alcohol at 20℃; for 0.333333h;
Stage #2: phenyl 2-bromoacetate In isopropyl alcohol at 0 - 20℃; for 2h;
92%
phenyl 2-bromoacetate
620-72-4

phenyl 2-bromoacetate

sodium salt of 2-nitroimidazole

sodium salt of 2-nitroimidazole

(2-Nitro-imidazol-1-yl)-acetic acid phenyl ester
165062-75-9

(2-Nitro-imidazol-1-yl)-acetic acid phenyl ester

Conditions
ConditionsYield
With 15-crown-5 In acetonitrile for 3h; Ambient temperature;91%
(S)-2-amino-3-((tert-butyldiphenylsilyl)oxy)propan-1-ol

(S)-2-amino-3-((tert-butyldiphenylsilyl)oxy)propan-1-ol

phenyl 2-bromoacetate
620-72-4

phenyl 2-bromoacetate

C21H27NO3Si

C21H27NO3Si

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In acetonitrile at 20℃; for 4h;91%
phenyl 2-bromoacetate
620-72-4

phenyl 2-bromoacetate

(1R,3S)-2-chloroethyl 1-[(R)-1-amino-2-hydroxyethyl]-8-benzyloxy-3-(dimethoxymethyl)-7-methoxy-6-methyl-3,4-dihydroisoquinoline-2(1H)-carboxylate
1414948-65-4

(1R,3S)-2-chloroethyl 1-[(R)-1-amino-2-hydroxyethyl]-8-benzyloxy-3-(dimethoxymethyl)-7-methoxy-6-methyl-3,4-dihydroisoquinoline-2(1H)-carboxylate

(1R,3S)-2-chloroethyl 8-(benzyloxy)-3-(dimethoxymethyl)-7-methoxy-6-methyl-1-[(R)-6-oxomorpholin-3-yl]-3,4-dihydroisoquinoline-2(1H)-carboxylate
1414948-69-8

(1R,3S)-2-chloroethyl 8-(benzyloxy)-3-(dimethoxymethyl)-7-methoxy-6-methyl-1-[(R)-6-oxomorpholin-3-yl]-3,4-dihydroisoquinoline-2(1H)-carboxylate

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In acetonitrile at 0 - 20℃; for 23.5h;91%
phenyl 2-bromoacetate
620-72-4

phenyl 2-bromoacetate

C10H13N3O3S

C10H13N3O3S

C12H13N3O4S

C12H13N3O4S

Conditions
ConditionsYield
With sulfuric acid; sodium acetate In acetonitrile for 0.333333h; Reflux;91%
(1R,3S)-3-Acetoxymethyl-8-allyloxy-1-((R)-1-amino-2-hydroxy-ethyl)-7-methoxy-6-methyl-3,4-dihydro-1H-isoquinoline-2-carboxylic acid allyl ester
874758-59-5

(1R,3S)-3-Acetoxymethyl-8-allyloxy-1-((R)-1-amino-2-hydroxy-ethyl)-7-methoxy-6-methyl-3,4-dihydro-1H-isoquinoline-2-carboxylic acid allyl ester

phenyl 2-bromoacetate
620-72-4

phenyl 2-bromoacetate

C25H32N2O8

C25H32N2O8

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In acetonitrile at 10℃; for 4h;90%
phenyl 2-bromoacetate
620-72-4

phenyl 2-bromoacetate

1-(4-hydroxy-6-methyl-2-oxo-2H-pyran-3-yl)ethan-1-one N-ethyl thiosemicarbazone

1-(4-hydroxy-6-methyl-2-oxo-2H-pyran-3-yl)ethan-1-one N-ethyl thiosemicarbazone

C13H15N3O4S

C13H15N3O4S

Conditions
ConditionsYield
With sulfuric acid; sodium acetate In acetonitrile for 0.166667h; Reflux;90%
phenyl 2-bromoacetate
620-72-4

phenyl 2-bromoacetate

4-methyl-N-(3-phenylprop-2-yn-1-yl)benzenesulfonamide
305837-95-0

4-methyl-N-(3-phenylprop-2-yn-1-yl)benzenesulfonamide

phenyl N-(3-phenylprop-2-yn-1-yl)-N-tosylglycinate

phenyl N-(3-phenylprop-2-yn-1-yl)-N-tosylglycinate

Conditions
ConditionsYield
With potassium carbonate In acetone at 20℃; for 16h;90%
phenyl 2-bromoacetate
620-72-4

phenyl 2-bromoacetate

3-acetyl-4-hydroxy-6-methyl-2H-pyran-2-one thiosemicarbazone
75843-20-8

3-acetyl-4-hydroxy-6-methyl-2H-pyran-2-one thiosemicarbazone

C11H11N3O4S

C11H11N3O4S

Conditions
ConditionsYield
With sulfuric acid; sodium acetate In acetonitrile for 0.333333h; Reflux;88%
phenyl 2-bromoacetate
620-72-4

phenyl 2-bromoacetate

(R)-1-amino-2-methyl-1-phenyl-propan-2-ol
110480-87-0

(R)-1-amino-2-methyl-1-phenyl-propan-2-ol

((R)-2-Hydroxy-2-methyl-1-phenyl-propylamino)-acetic acid phenyl ester

((R)-2-Hydroxy-2-methyl-1-phenyl-propylamino)-acetic acid phenyl ester

Conditions
ConditionsYield
With methyloxirane In acetonitrile at 50℃;81%
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

phenyl 2-bromoacetate
620-72-4

phenyl 2-bromoacetate

tert-butyl (5R)-5-[(1S,2S)-1-benzyloxy-3-(3,5-difluorophenyl)-2-methylpropyl]-2-oxomorpholine-4-carboxylate
883442-71-5

tert-butyl (5R)-5-[(1S,2S)-1-benzyloxy-3-(3,5-difluorophenyl)-2-methylpropyl]-2-oxomorpholine-4-carboxylate

Conditions
ConditionsYield
Stage #1: (2R,3R,4S)-2-amino-3-benzyloxy-4-dibenzylamino-5-(3,5-difluorophenyl)-pentan-1-ol; phenyl 2-bromoacetate With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 14h;
Stage #2: di-tert-butyl dicarbonate In N,N-dimethyl-formamide at 20℃; for 20h;
81%
phenyl 2-bromoacetate
620-72-4

phenyl 2-bromoacetate

(R)-Phenylglycinol
56613-80-0

(R)-Phenylglycinol

(R)-5-phenyl-3,4,5,6-tetrahydro-2H-1,4-oxazin-2-one
121269-45-2

(R)-5-phenyl-3,4,5,6-tetrahydro-2H-1,4-oxazin-2-one

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In acetonitrile for 18h; Ambient temperature;78%
With N-ethyl-N,N-diisopropylamine In acetonitrile24%
With N-ethyl-N,N-diisopropylamine In acetonitrile
phenyl 2-bromoacetate
620-72-4

phenyl 2-bromoacetate

2-(1-(4-hydroxy-6-methyl-2-oxo-2H-pyran-3-yl)ethylidene)-N-phenylhydrazinecarbothioamide

2-(1-(4-hydroxy-6-methyl-2-oxo-2H-pyran-3-yl)ethylidene)-N-phenylhydrazinecarbothioamide

C17H15N3O4S

C17H15N3O4S

Conditions
ConditionsYield
With sulfuric acid; sodium acetate In acetonitrile for 0.333333h; Reflux;78%
phenyl 2-bromoacetate
620-72-4

phenyl 2-bromoacetate

diethyl 2-allyl-2-(4-methoxyphenethyl)malonate
1444623-25-9

diethyl 2-allyl-2-(4-methoxyphenethyl)malonate

silver(I) acetate
563-63-3

silver(I) acetate

C29H36O9

C29H36O9

Conditions
ConditionsYield
With tris[2-phenylpyridinato-C2,N]iridium(III) In dichloromethane at 25℃; Irradiation;78%
phenyl 2-bromoacetate
620-72-4

phenyl 2-bromoacetate

(Rp)-13-iodo-1,4(1,4)-dibenzenacyclohexaphan-12-ol

(Rp)-13-iodo-1,4(1,4)-dibenzenacyclohexaphan-12-ol

phenyl (Rp)-2-[(13-iodo-1,4(1,4)-dibenzenacyclohexaphane-12-yl)oxy]acetate

phenyl (Rp)-2-[(13-iodo-1,4(1,4)-dibenzenacyclohexaphane-12-yl)oxy]acetate

Conditions
ConditionsYield
With potassium carbonate In acetone at 0 - 20℃; for 10h;77%
phenyl 2-bromoacetate
620-72-4

phenyl 2-bromoacetate

dimethyl 2-(3-phenylprop-2-yn-1-yl)malonate
346621-58-7

dimethyl 2-(3-phenylprop-2-yn-1-yl)malonate

2,2-dimethyl 1-phenyl 5-phenylpent-4-yne-1,2,2-tricarboxylate

2,2-dimethyl 1-phenyl 5-phenylpent-4-yne-1,2,2-tricarboxylate

Conditions
ConditionsYield
Stage #1: dimethyl 2-(3-phenylprop-2-yn-1-yl)malonate With sodium hydride In tetrahydrofuran; mineral oil at 20℃; for 0.75h; Cooling with ice;
Stage #2: phenyl 2-bromoacetate In tetrahydrofuran; mineral oil at 0℃; for 2.5h;
76%
phenyl 2-bromoacetate
620-72-4

phenyl 2-bromoacetate

(2S)-2-phenylglycinol
20989-17-7

(2S)-2-phenylglycinol

(5S)-5-phenylmorpholin-2-one
144896-92-4

(5S)-5-phenylmorpholin-2-one

Conditions
ConditionsYield
75%
With N-ethyl-N,N-diisopropylamine In acetonitrile at 20℃; for 24h;70%
With N-ethyl-N,N-diisopropylamine In acetonitrile Inert atmosphere;53%
With N-ethyl-N,N-diisopropylamine In acetonitrile at -5 - 20℃; for 20.5h; Inert atmosphere;53%
Stage #1: (2S)-2-phenylglycinol With N-ethyl-N,N-diisopropylamine In acetonitrile
Stage #2: phenyl 2-bromoacetate In acetonitrile at 20℃; for 3.75h;
phenyl 2-bromoacetate
620-72-4

phenyl 2-bromoacetate

(1S)-1-amino-2-methyl-1-phenylpropan-2-ol
110480-86-9

(1S)-1-amino-2-methyl-1-phenylpropan-2-ol

(S)-6,6-dimethyl-5-phenylmorpholin-2-one
723262-92-8

(S)-6,6-dimethyl-5-phenylmorpholin-2-one

Conditions
ConditionsYield
Stage #1: phenyl 2-bromoacetate; (1S)-1-amino-2-methyl-1-phenylpropan-2-ol With methyloxirane In acetonitrile at 80℃; for 4h;
Stage #2: In toluene for 15h; Heating;
75%
phenyl 2-bromoacetate
620-72-4

phenyl 2-bromoacetate

4-(N,N-dimethylamino)-2,2,6,6-tetramethylpiperidin-1-oxyl
71335-68-7

4-(N,N-dimethylamino)-2,2,6,6-tetramethylpiperidin-1-oxyl

Br(1-)*C19H30N2O3(1+)
1051372-91-8

Br(1-)*C19H30N2O3(1+)

Conditions
ConditionsYield
In tetrahydrofuran at 20℃; for 8h;75%
1,1-Diphenylethylene
530-48-3

1,1-Diphenylethylene

phenyl 2-bromoacetate
620-72-4

phenyl 2-bromoacetate

5,5-diphenyldihydrofuran-2(3H)-one
7746-94-3

5,5-diphenyldihydrofuran-2(3H)-one

Conditions
ConditionsYield
With lithium tetrafluoroborate; fac-tris[2-phenylpyridinato-C2,N]iridium(III) In water; acetonitrile at 20℃; for 24h; Mechanism; Inert atmosphere; Irradiation; regioselective reaction;75%
pyridine
110-86-1

pyridine

phenyl 2-bromoacetate
620-72-4

phenyl 2-bromoacetate

1-(2-oxo-2-phenoxyethyl)pyridin-1-ium bromide

1-(2-oxo-2-phenoxyethyl)pyridin-1-ium bromide

Conditions
ConditionsYield
In tetrahydrofuran at 60℃; for 12h; Inert atmosphere;74.7%
phenyl 2-bromoacetate
620-72-4

phenyl 2-bromoacetate

(4aS,9aR)-4,4a,9,9a-tetrahydroindeno[2,1-b][1,4]oxazin-2(3H)-one
1428243-82-6

(4aS,9aR)-4,4a,9,9a-tetrahydroindeno[2,1-b][1,4]oxazin-2(3H)-one

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In tetrahydrofuran at 20℃; for 3h; Inert atmosphere;72.1%
phenyl 2-bromoacetate
620-72-4

phenyl 2-bromoacetate

tris-4,4,5,5,6,6,7,7,8,8,9,9,9-tridecafluorononyl allyl stannane

tris-4,4,5,5,6,6,7,7,8,8,9,9,9-tridecafluorononyl allyl stannane

phenyl pent-4-enoate
51231-09-5

phenyl pent-4-enoate

Conditions
ConditionsYield
With α,α,α-trifluorotoluene at 25℃; Irradiation;72%

620-72-4Relevant articles and documents

Biomimetic synthesis and anti-inflammatory evaluation of violacin A analogues

Wu, Wenxi,Mu, Yu,Liu, Bo,Wang, Zixuan,Guan, Peipei,Han, Li,Jiang, Mingguo,Huang, Xueshi

, (2021/04/23)

Violacin A, a chromanone derivative, isolated from a fermentation broth of Streptomyces violaceoruber, has excellent anti-inflammatory potential. Herein, a biogenetically modeled approach to synthesize violacin A and twenty-five analogues was described, which involved the preparation of aromatic polyketide precursor through Claisen condensation and its spontaneous cyclization. The inhibitory effect on nitric oxide (NO) production of all synthetic molecules was evaluated by lipopolysaccharide (LPS)-induced Raw264.7 cells. The results revealed that introduction of aliphatic amine moieties on C-7 obviously improved the anti-inflammation effect of violacin A, and also the aromatic ether instead of ketone group at side chain was favorable to increase the activity. Among them, analogue 7a and 16d were screened as the most effective anti-inflammatory candidates. Molecular mechanism research revealed that 7a and 16d acquired anti-inflammatory ability due to the inhibition of NF-κB signaling pathway.

Visible-Light-Assisted Gold-Catalyzed Fluoroarylation of Allenoates

Feng, Chao,Tang, Hai-Jun,Zhang, Xinggui,Zhang, Yu-Feng

supporting information, p. 5242 - 5247 (2020/02/28)

A strategically novel synthetic method for the fluoroarylation of allenic ester was developed that enables the expedient construction of a host of β-fluoroalkyl-containing cinnamate derivatives. The reaction proceeds through visible-light-promoted gold redox catalysis, occurs smoothly under very mild reaction conditions, accommodates a large variety of functional groups, and more importantly allows the incorporation of fluorine and aryl groups with excellent regio- and stereoselectivity. The concomitant activation mode for both the allene motif and the hydrogen fluoride is key for the success of the reaction.

A Tunable Route to Prepare α,β-Unsaturated Esters and α,β-Unsaturated-γ-Keto Esters through Copper-Catalyzed Coupling of Alkenyl Boronic Acids with Phosphorus Ylides

Bi, Hong-Yan,Liu, Feng-Ping,Liang, Cui,Su, Gui-Fa,Mo, Dong-Liang

supporting information, p. 1510 - 1516 (2018/03/05)

A tunable strategy to prepare α,β-unsaturated esters and α,β-unsaturated-γ-keto esters in good to excellent yields was developed through copper-catalyzed oxidative coupling of phosphorus ylides with alkenyl boronic acids under mild conditions. The reaction without water afforded α,β-unsaturated esters, ketones, and amides while α,β-unsaturated-γ-keto esters, 1,4-α,β-unsaturated diketones and α,β-unsaturated-γ-keto amides were obtained when using 5.0 equiv. of water. H2O18 labeling experiments showed that water played an important role in the formation of α,β-unsaturated-γ-keto esters. A plausible formation mechanism for α,β-unsaturated esters and α,β-unsaturated-γ-keto esters was proposed based on mechanistic studies. Phosphonium salts could also be used directly as coupling partners instead of phosphorus ylides. The reaction exhibited a broad substrate scope, good functional group tolerance, good regioselectivity, and diverse coupling products. (Figure presented.).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 620-72-4